Home » International Scholarships for Students » AstraZeneca-Funded Non-Clinical PhD Studentship in UK

AstraZeneca-Funded Non-Clinical PhD Studentship in UK

To provide a funding source to international students undertaking their higher studies in UK, the University of Cambridge has organized the AstraZeneca-Funded Non-Clinical PhD Studentship for the academic year 2025-2026.

Applicants must hold (or expect to obtain) at least a 2:1 honours degree or master’s in a relevant field, with laboratory experience required. Skills in data analysis or small animal models are desirable. Open to UK (Home) students and international applicants eligible for Home fee status.

  • Award
  • Application Process
  • Clarity of Information
4.5
Sending
User Review
0 (0 votes)

Founded in 1209, the University of Cambridge is one of the world’s oldest and most prestigious universities. Renowned for its excellence in teaching and groundbreaking research, Cambridge fosters innovation across a wide range of disciplines. With its rich academic heritage, world-class facilities, and vibrant international community, the university continues to produce leaders, thinkers, and innovators who make a global impact.

Application Deadline: 2 October 2025

Brief Description

  • University or Organization: University of Cambridge, Department of Medicine (VPD Heart & Lung Research Institute)

  • Department: Medicine – VPD Heart & Lung Research Institute

  • Course Level: PhD (Non-clinical)

  • Award: Fully funded studentship (Stipend, tuition fees, consumables, and training support)

  • Access Mode: Online application through Cambridge Applicant Portal

  • Number of Awards: 1

  • Nationality: Open to UK (Home) students and eligible international applicants (Home fee status required)

  • The award can be taken in: United Kingdom

Eligibility

  • Eligible Countries: Open to UK (Home) applicants and international students eligible for Home fee status.

  • Acceptable Course or Subjects: The scholarship will be awarded for a PhD in Medicine (Cardiometabolic Research).

  • Admissible Criteria:

    • Applicants must hold (or expect to obtain) at least a 2:1 Honours degree or a Master’s in a relevant discipline.

    • Laboratory research experience is essential.

    • Skills in data analysis or small animal models are desirable.

    • Self-funding is not permitted.

How to Apply

  • Apply via the University of Cambridge Applicant Portal.

  • Quote the project title and supervisors (Dr Ana Vujic / Prof Antonio Vidal-Puig).

  • Applications must include:

    • Curriculum Vitae (CV)

    • Academic transcripts

    • Statement of purpose (research interests, motivation, and suitability)

    • Two academic references (submitted by the deadline)

  • Shortlisted candidates will be interviewed between October–November 2025 (in person or online).

  • Informal enquiries can be made to Dr Ana Vujic ([email protected]) or Prof Antonio Vidal-Puig ([email protected]).

Benefits

  • Competitive stipend of £21,500/year

  • Home tuition fees covered

  • £33,000 consumables allowance

  • £5,000 training and travel support

  • Advanced training in molecular analysis, mass spectrometry, multi-omics, and preclinical cardiometabolic models

  • Professional development in research integrity, ethical design, and data stewardship

  • Unique collaboration with AstraZeneca, with exposure to drug discovery and translational science

  • Access to Cambridge’s world-class research facilities and cardiovascular research community.

Apply Now